These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. Hoogkamp-Korstanje JA. J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498 [Abstract] [Full Text] [Related]
5. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates. Cunha BA, Qadri SM, Ueno Y, Walters EA, Domenico P. J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067 [Abstract] [Full Text] [Related]
6. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. McCloskey L, Moore T, Niconovich N, Donald B, Broskey J, Jakielaszek C, Rittenhouse S, Coleman K. J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():13-21. PubMed ID: 10824027 [Abstract] [Full Text] [Related]
7. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA, Gemifloxacin Surveillance Study Research Group. Diagn Microbiol Infect Dis; 2001 Apr; 40(1-2):51-7. PubMed ID: 11448564 [Abstract] [Full Text] [Related]
8. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR. Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087 [Abstract] [Full Text] [Related]
14. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates. Bassetti M, Dembry LM, Farrel PA, Callan DA, Andriole VT. Antimicrob Agents Chemother; 2002 Jan; 46(1):234-8. PubMed ID: 11751142 [Abstract] [Full Text] [Related]
15. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Visalli MA, Bajaksouzian S, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669 [Abstract] [Full Text] [Related]
16. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. Wise R, Brenwald NP, Andrews JM, Boswell F. J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816 [Abstract] [Full Text] [Related]
17. The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria. Bowker KE, Wootton M, Holt HA, Reeves DS, MacGowan AP. J Antimicrob Chemother; 1996 Aug; 38(2):271-81. PubMed ID: 8877542 [Abstract] [Full Text] [Related]
19. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE. Chemotherapy; 1998 Aug; 44(2):85-93. PubMed ID: 9551237 [Abstract] [Full Text] [Related]